Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
China
· Delayed Price · Currency is CNY 8.12
-0.08 (-0.98%)
Mar 11, 2026, 2:15 PM CST
SHE:300636 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,444 | 3,331 | 4,423 | 5,134 | 5,427 | 2,898 | Upgrade
|
| Market Cap Growth | 2.72% | -24.67% | -13.86% | -5.39% | 87.27% | 20.61% | Upgrade
|
| Enterprise Value | 3,209 | 3,771 | 4,694 | 5,587 | 5,986 | 3,169 | Upgrade
|
| Last Close Price | 8.20 | 7.93 | 10.44 | 14.63 | 17.31 | 9.22 | Upgrade
|
| PE Ratio | 36.44 | 31.26 | 41.73 | 51.00 | 66.90 | 41.37 | Upgrade
|
| Forward PE | - | 19.68 | 33.46 | 36.12 | 43.57 | 48.44 | Upgrade
|
| PS Ratio | 4.17 | 4.39 | 6.12 | 7.13 | 9.16 | 6.66 | Upgrade
|
| PB Ratio | 1.45 | 1.44 | 1.99 | 3.89 | 6.11 | 3.55 | Upgrade
|
| P/TBV Ratio | 1.46 | 1.46 | 2.01 | 3.95 | 6.26 | 3.65 | Upgrade
|
| P/FCF Ratio | - | 22.41 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 10.89 | 11.68 | 27.01 | 26.20 | 41.32 | 36.19 | Upgrade
|
| EV/Sales Ratio | 3.89 | 4.97 | 6.50 | 7.76 | 10.11 | 7.28 | Upgrade
|
| EV/EBITDA Ratio | 13.62 | 18.54 | 28.91 | 31.75 | 42.66 | 23.11 | Upgrade
|
| EV/EBIT Ratio | 36.84 | 42.05 | 50.02 | 50.81 | 67.02 | 37.37 | Upgrade
|
| EV/FCF Ratio | -130.45 | 25.36 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.30 | 0.35 | 0.47 | 0.91 | 0.70 | Upgrade
|
| Debt / EBITDA Ratio | 2.48 | 3.44 | 4.71 | 3.47 | 5.75 | 4.19 | Upgrade
|
| Debt / FCF Ratio | - | 4.73 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | 0.14 | 0.09 | 0.36 | 0.73 | 0.36 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.00 | 1.53 | 1.18 | 2.68 | 4.63 | 2.15 | Upgrade
|
| Net Debt / FCF Ratio | 9.53 | 2.10 | -3.77 | -4.09 | -2.21 | -1.96 | Upgrade
|
| Asset Turnover | 0.25 | 0.23 | 0.26 | 0.35 | 0.35 | 0.35 | Upgrade
|
| Inventory Turnover | 1.10 | 1.00 | 0.98 | 1.13 | 1.19 | 0.99 | Upgrade
|
| Quick Ratio | 1.62 | 0.98 | 0.93 | 0.41 | 0.71 | 1.26 | Upgrade
|
| Current Ratio | 2.56 | 2.08 | 1.71 | 1.32 | 1.78 | 2.58 | Upgrade
|
| Return on Equity (ROE) | 4.04% | 4.70% | 5.98% | 9.12% | 9.52% | 9.20% | Upgrade
|
| Return on Assets (ROA) | 1.66% | 1.71% | 2.14% | 3.30% | 3.31% | 4.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.57% | 3.31% | 4.20% | 6.26% | 6.19% | 7.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 3.20% | 3.70% | 6.50% | 5.80% | 7.00% | Upgrade
|
| Earnings Yield | 2.74% | 3.20% | 2.40% | 1.96% | 1.49% | 2.42% | Upgrade
|
| FCF Yield | -0.71% | 4.46% | -1.15% | -2.25% | -5.41% | -5.17% | Upgrade
|
| Dividend Yield | 0.50% | 0.51% | 0.38% | 0.31% | 0.23% | 0.38% | Upgrade
|
| Payout Ratio | 13.52% | 27.32% | 25.39% | 31.90% | 26.87% | 32.53% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | -10.39% | -9.89% | -2.55% | -9.05% | 0.43% | Upgrade
|
| Total Shareholder Return | 0.51% | -9.89% | -9.51% | -2.24% | -8.82% | 0.81% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.